John Orwin
Chief Executive Officer chez ATRECA, INC.
Fortune : 178 715 $ au 31/03/2024
Profil
John A.
Orwin is currently the President, CEO, CFO & Director at Atreca, Inc. He is also the Chairman at AnaptysBio, Inc. and Cargo Therapeutics, Inc. Additionally, he serves as a Director at the Biotechnology Innovation Organization and as an Independent Director at Travere Therapeutics, Inc. In the past, Mr. Orwin held positions such as Chief Executive Officer at Relypsa, Inc., Chairman at Affymax, Inc., and Independent Director at Array BioPharma, Inc. He also served as an Independent Director at Seagen Inc., NeurogesX, Inc., and SangStat Medical Corp.
Furthermore, he worked as the Senior Vice President-BioOncology Business Unit at Genentech, Inc. and as the Franchise Vice President-Oncology at Johnson & Johnson.
Mr. Orwin's education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from New York University and The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/05/2023 | 22 375 ( 0,03% ) | 172 511 $ | 31/03/2024 | |
ATRECA, INC. CLASS A
0,20% | 01/09/2023 | 77 541 ( 0,20% ) | 6 203 $ | 31/03/2024 |
CARGO THERAPEUTICS, INC.
-.--% | 10/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
ANAPTYSBIO, INC.
-.--% | 03/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de John Orwin
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Board Member | 23/03/2017 |
| ATRECA, INC. | Chief Executive Officer | 19/04/2018 |
| CARGO THERAPEUTICS, INC. | Chairman | 01/09/2022 |
| ANAPTYSBIO, INC. | Chairman | 15/09/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Anciens postes connus de John Orwin
| Sociétés | Poste | Fin |
|---|---|---|
| SEAGEN INC. | Director/Board Member | 14/12/2022 |
| ARRAY TECHNOLOGIES, INC. | Director/Board Member | 30/07/2019 |
| RELYPSA INC | Chief Executive Officer | 01/06/2017 |
| AFFYMAX, INC. | Chief Executive Officer | 06/06/2013 |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de John Orwin
| Rutgers State University of New Jersey | Undergraduate Degree |
| New York University | Masters Business Admin |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| AFFYMAX, INC. | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| SangStat Medical Corp. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Health Technology |
